SYK, A NOVEL THERAPEUTIC TARGET FOR PTLD, DRIVES EPSTEIN BARR VIRUS (EBV)+ B CELL LYMPHOMA GROWTH AND SURVIVAL THROUGH ACTIVATION OF THE PI3K/AKT PATHWAY
Hatton, O, Lambert, S, Vaysberg, M, Sharman, J, Krams, S M., Esquivel, C O., Martinez, O M.Volume:
86
Language:
english
Journal:
Transplantation
DOI:
10.1097/01.tp.0000332036.17315.6a
Date:
July, 2008
File:
PDF, 76 KB
english, 2008